0001209191-18-058826.txt : 20181115 0001209191-18-058826.hdr.sgml : 20181115 20181115192319 ACCESSION NUMBER: 0001209191-18-058826 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181115 FILED AS OF DATE: 20181115 DATE AS OF CHANGE: 20181115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRYNJELSEN SEAN CENTRAL INDEX KEY: 0001669976 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38738 FILM NUMBER: 181188411 MAIL ADDRESS: STREET 1: C/O SAGENT PHARMACEUTICALS, INC. STREET 2: 1901 NORTH ROSELLE ROAD, SUITE 700 CITY: SCHAUMBURG STATE: IL ZIP: 60195 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eton Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001710340 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 371858472 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12264 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-704-4040 MAIL ADDRESS: STREET 1: 12264 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-11-15 0 0001710340 Eton Pharmaceuticals, Inc. ETON 0001669976 BRYNJELSEN SEAN 21925 W FIELD PKWY #235 DEER PARK IL 60010 1 1 0 0 President & CEO Common Stock 2018-11-15 4 C 0 24940 A 24940 I by LLC Common Stock 2018-11-15 4 P 0 10000 6.00 A 1010000 D Series A Convertible Preferred Stock 2018-11-15 4 C 0 23000 0.00 D Common Stock 24940 0 I by LLC Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock. The shares have no expiration date. /s/ W. Wilson Troutman, Attorney-in-fact 2018-11-15